View in EDS

WS09.02 Biomarkers for monitoring the effect of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis.

Saved in:
Bibliographic Details
Title: WS09.02 Biomarkers for monitoring the effect of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis.
Authors: Dolce, D.1 (AUTHOR), Francalanci, M.1 (AUTHOR), Orioli, T.1 (AUTHOR), Campana, S.1 (AUTHOR), Ravenni, N.1 (AUTHOR), Camera, E.1 (AUTHOR), Fevola, C.1 (AUTHOR), Cavicchi, M.C.1 (AUTHOR), Galici, V.1 (AUTHOR), Neri, A.S.1 (AUTHOR), Terlizzi, V.1 (AUTHOR), Taccetti, G.1 (AUTHOR)
Source: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS16-S17. 2p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first